These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22745611)

  • 1. Out-of-plan pharmacy use by members of a managed care organization.
    Delate T; Albrecht G; Olson KL
    Perm J; 2012; 16(2):15-21. PubMed ID: 22745611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Out-of-plan pharmacy use: insights into patient behavior.
    Delate T; Block AP; Kurz D; Billups SJ
    Am J Manag Care; 2014; 20(12):995-1001. PubMed ID: 25526388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of electronic prescribing on formulary compliance and generic drug utilization in the ambulatory care setting: a retrospective analysis of administrative claims data.
    Ross SM; Papshev D; Murphy EL; Sternberg DJ; Taylor J; Barg R
    J Manag Care Pharm; 2005 Jun; 11(5):410-5. PubMed ID: 15934800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Web-based survey to assess the perceptions of managed care organization representatives on use of copay subsidy coupons for prescription drugs.
    Nemlekar P; Shepherd M; Lawson K; Rush S
    J Manag Care Pharm; 2013 Oct; 19(8):602-8. PubMed ID: 24074006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Employer drug benefit plans and spending on prescription drugs.
    Joyce GF; Escarce JJ; Solomon MD; Goldman DP
    JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
    Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Muriel AC; Frank RG
    Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Special report: the value of pharmaceuticals. Data watch. Managed care and prescription drugs.
    Bus Health; 1991; [VALUE]():6-7. PubMed ID: 10116288
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug benefit plans under managed care: to what extent do older subscribers selecting less drug coverage put themselves at increased financial risk?
    Andrade SE; Gurwitz JH
    J Am Geriatr Soc; 2002 Jan; 50(1):178-81. PubMed ID: 12028265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a three-tier formulary on antidepressant utilization and expenditures.
    Hodgkin D; Parks Thomas C; Simoni-Wastila L; Ritter GA; Lee S
    J Ment Health Policy Econ; 2008 Jun; 11(2):67-77. PubMed ID: 18509214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
    Murry L; Gerleman B; Urick B; Urmie J
    J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCO-PBM (managed care organization-prescription benefit management) partnerships holding down drug trend.
    Alexander W
    Exec Solut Healthc Manag; 1998 Dec; 1(10):1, 4-6. PubMed ID: 10338773
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
    Gurwitz JH; McLaughlin TJ; Fish LS
    Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health plan member experience with point-of-service prescription step therapy.
    Cox ER; Henderson R; Motheral BR
    J Manag Care Pharm; 2004; 10(4):291-8. PubMed ID: 15298527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The price of pharmaceuticals given managed care health insurance membership.
    Brotman BA
    Pharm Pract Manag Q; 2000 Jul; 20(2):16-9. PubMed ID: 11184047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of risk management plans: a case study of pemoline using pharmacy claims data.
    Morrato EH; Staffa JA
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):104-12. PubMed ID: 16821248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists.
    Andrade SE; Gurwitz JH; Fish LS
    Med Care; 1999 Apr; 37(4):424-30. PubMed ID: 10213023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare Prescription Drug Plan Enrollees Report Less Positive Experiences Than Their Medicare Advantage Counterparts.
    Elliott MN; Landon BE; Zaslavsky AM; Edwards C; Orr N; Beckett MK; Mallett J; Cleary PD
    Health Aff (Millwood); 2016 Mar; 35(3):456-63. PubMed ID: 26953300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Undocumented source of pharmacy benefit manager revenue.
    Siracuse MV; Clark BE; Garis RI
    Am J Health Syst Pharm; 2008 Mar; 65(6):552-7. PubMed ID: 18319501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of insurance type with costs of dispensed drugs.
    Mott DA; Kreling DH
    Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.